One point of interest will be how the treatments are priced.
We already from JCR that the Japanese heath system will pay well in advance of the cost of a painkiller for a course of treatment in the aGVHD space.
Equally life threatening, probably more so, is what happens down the track to those people who survive long enough to get an LVAD and do not get a heart transplant.
It is about avoiding the ongoing cost to health systems and to peoples lives.
MSB Price at posting:
$1.51 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)